Skip to content
Sample Page
Author:
Black Hawk Acquisition Corp.
Posted Date:
March 18, 2026
Vesicor Therapeutics Appoints Michael Tolentino, M.D., as Chief Executive Officer
Black Hawk Acquisition Corp.
March 18, 2026